Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Advanced Medical Isotope Corporation (RDGL) had Free Cash Flow per Share of $-0.00 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.03M |
|
$-0.83M |
|
$0.04M |
|
$-0.01M |
|
$0.89M |
|
$-0.86M |
|
$0.03M |
|
$-0.83M |
|
$-0.83M |
|
$-0.83M |
|
$-0.83M |
|
$-0.83M |
|
$-0.83M |
|
$-0.86M |
|
$-0.86M |
|
448.24M |
|
448.24M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$3.30M |
|
-- |
|
-- |
|
$3.30M |
|
$0.12M |
|
-- |
|
-- |
|
$0.12M |
|
$-6.16M |
|
$3.19M |
|
$3.19M |
|
453.41M |
|
| Cash Flow Statement Financials | |
$-0.46M |
|
-- |
|
$1.51M |
|
$2.21M |
|
$3.27M |
|
$1.05M |
|
$0.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.96% |
|
-3228.40% |
|
-3228.40% |
|
-- |
|
-3120.59% |
|
-3120.59% |
|
$-0.46M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
1.69 |
|
3.07 |
|
29.29 |
|
13.54% |
|
-26.19% |
|
-25.28% |
|
-26.19% |
|
$0.01 |
|
|
Free Cash Flow per Share |
$-0.00 |
$-0.00 |
|